BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20931422)

  • 1. Efficacy of probiotics in Helicobacter pylori eradication therapy.
    Yaşar B; Abut E; Kayadıbı H; Toros B; Sezıklı M; Akkan Z; Keskın Ö; Övünç Kurdaş O
    Turk J Gastroenterol; 2010 Sep; 21(3):212-7. PubMed ID: 20931422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.
    Sheu BS; Wu JJ; Lo CY; Wu HW; Chen JH; Lin YS; Lin MD
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1669-75. PubMed ID: 12197847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
    Sezikli M; Çetinkaya ZA; Güzelbulut F; Yeşil A; Coşgun S; Kurdaş OÖ
    J Clin Pharm Ther; 2012 Jun; 37(3):282-5. PubMed ID: 21740452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
    Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
    Asian Pac J Cancer Prev; 2015; 16(12):4885-90. PubMed ID: 26163609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
    Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
    Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection.
    Du YQ; Su T; Fan JG; Lu YX; Zheng P; Li XH; Guo CY; Xu P; Gong YF; Li ZS
    World J Gastroenterol; 2012 Nov; 18(43):6302-7. PubMed ID: 23180952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential therapy for Helicobacter pylori eradication.
    Yakut M; Çinar K; Seven G; Bahar K; Özden A
    Turk J Gastroenterol; 2010 Sep; 21(3):206-11. PubMed ID: 20931421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.
    Yoon H; Kim N; Kim JY; Park SY; Park JH; Jung HC; Song IS
    J Gastroenterol Hepatol; 2011 Jan; 26(1):44-8. PubMed ID: 21175792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone.
    Tolone S; Pellino V; Vitaliti G; Lanzafame A; Tolone C
    Ital J Pediatr; 2012 Oct; 38():63. PubMed ID: 23114016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.
    Li BZ; Threapleton DE; Wang JY; Xu JM; Yuan JQ; Zhang C; Li P; Ye QL; Guo B; Mao C; Ye DQ
    BMJ; 2015 Aug; 351():h4052. PubMed ID: 26290044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.